Clinical Trial Update: RCT of ChondroCelect® (in an ACI Procedure) vs Microfracture in the Repair of Cartilage Defects of the Knee [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing ChondroCelect autologous chondrocyte therapy to microfracture for knee articular cartilage defects; results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defects of the Knee

Drugs mentioned

• ChondroCelect (autologous chondrocyte therapy)

Snippet

Sponsor: TiGenix n.v. | Conditions: Articular Cartilage Lesion of the Femoral Condyle | Phase 3 | Status: COMPLETED | Results posted: 2010-01-18